Skip to main content
. 2017 Sep 16;8(48):84373–84383. doi: 10.18632/oncotarget.21033

Table 3. Distribution of mtDNA haplogroup among HCC pairs/subjects.

mtDNA haplogroup M N P
D G M7 M8 M12 A N9 R9(F) R11 B H2
HCC patients, n = 86 18 4 14 5 1 8 5 20 2 8 1 0.553
Subjects with somatic variants, n = 35 8 2 5 2 1 6 1 6 1 2 1 0.755
Tumor tissues with reduced mtDNA content, n = 50 10 2 8 3 1 5 2 13 1 5 0.879